Results 91 to 100 of about 8,311 (216)
Penyakit Waldenstrom Makroglobulinemia [PDF]
Penyakit Waldenstrom Makroglobulinemia adalah kelainan limfoproliferatif sel B yang tidak umum, ditandai dengan infiltrasi sumsum tulang dan produksi immunoglobulin monoklonal IgM.
Wirawan, R. (Riadi) +1 more
core
Managing complications secondary to Waldenstrom's macroglobulinemia
Introduction: Waldenstrom's macroglobulinemia (WM) is a rare lymphoma characterized by the accumulation of IgM-secreting lymphoplasmacytic cells in the bone marrow and other organs. Clinical sequelae relate to direct tissue infiltration by malignant
Pessach, Ilias +2 more
core +1 more source
International prognostic scoring system for Waldenstrom macroglobulinemia
Recently, many new drugs have been developed for the treatment of Waldenstrom macroglobulinemia (WM). To optimize the treatment according to the prognosis and to facilitate the comparison of trials, we developed an International Prognostic Scoring System
Merlini +15 more
core +1 more source
Waldenstrom Macroglobulinemia Recurrence with Bing–Neel Syndrome Presentation
Bing–Neel syndrome (BNS) is a rare condition that may occur in patients with Waldenstrom macroglobulinemia (WM) and is caused by lymphoplasmacytic infiltration into the central nervous system.
Raffaella Capasso +3 more
core +1 more source
An Atypical Case of Relapsing Polychondritis Associated With Waldenström Macroglobulinemia
Relapsing polychondritis is a rare disease characterized by relapsing-remitting inflammation of cartilage and has been found to be associated as a paraneoplastic syndrome to hematologic malignancies.
Robin H. Lo, Bavani Nadeswaran
doaj +1 more source
OBJECTIVE: NA. BACKGROUND: Waldenstrom\u27s macroglobulinemia is a chronic lymphoproliferative disorder characterized by IgM overproduction and plasmacytoid lymphocyte proliferation.
Shastry, Sathvik, MD +3 more
core
Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor
The course of clonal evolution of 2 related clones in the blood of a patient with Waldenstrom macroglobulinemia (WM) indicates the functional importance for the expression of the B-cell receptor for the survival of these malignant cells.
Robert A. Kyle +5 more
core +1 more source
Current and novel BTK inhibitors in Waldenstrom's macroglobulinemia
The current therapeutic approach in Waldenstrom's macroglobulinemia (WM) is being driven by insights in disease biology and genomic landscape. Bruton's tyrosine kinase (BTK) plays a key role in signaling pathways for the survival of WM clone ...
Fotiou +4 more
core
Waldenstrom's macroglobulinemia
The clinical manifestations of Waldenstrom’s macroglobulinemia are related to direct tumor infiltration and to the unique properties of the immunoglobulin M monoclonal protein.
Matsouka, C, Galani, E, Dimopoulos, MA
core +1 more source

